VALIDATED EXECUTIVE ENGAGEMENTS
POOL + OUTREACH
INTERACTIONS
PARTICIPANTS
VALIDATIONS
* Login to view program details and full enterprise executive list.
DATE
SEPTEMBER 2020
TABLES
54
PAGES
163
EDITION
17
PRICE
USD $5600
The World of Nanobiotechnology is Changing Fast!
It's Time to Identify Upcoming Revenue Pockets & Growth Areas.
INSIDER ACCESS PRIVILEGES
KEY DIFFERENTIATORS
* A review of 262 off-the-shelf market report publishers worldwide.
WHAT SETS US APART
Client companies can access multiple features on our MarketGlass™ platform.
Clients have full-stack insider access to our ongoing primary research program. We have a very successful incentive driven primary research program that benefits participating executives regardless of their purchase decision. Our platform presents a unique opportunity to collaborate with peers and review competitors’ inputs and response clusters.
Detailed engagement stats are presented for every company and executive contacted. This is made available for our client reviews. (no other publisher offers this!)
A full-stack access to clients of all primary and secondary source content. This can often run into thousands of pages.
Where relevent and possible we present competitive brands.
Peer-to-peer online interactive collaborations. Allows for team curated bespoke analytics.
Customers can update and build bespoke versions of our analytics. Bespoke updates are fulfilled within a two-day turnaround.
Discretely bounce off queries to participant pool of executives. Our embedded AI selectively pings participants geographically and by domain acumen.
We pride in our commitment to provide support to our clients. We go beyond the scope of the study to get you timely answers.
Unlike the industry’s published PDF’s that are frozen in time from date of release, our research programs are ongoing and dynamic. Our reports are updated whenever there’s a major event impacting the marketplace. Your license offers seamless updates for one year.
All updates are offered for one year from date of your purchase without charge. Clients can opt for annual auto renewal and stay current without interruption.
| I. INTRODUCTION, METHODOLOGY & REPORT SCOPE |
| II. EXECUTIVE SUMMARY |
| 1. MARKET OVERVIEW |
| A Curtain Raiser |
| Recent Market Activity |
| Nanobiotechnology - The Next Big Thing |
| An Insight into the Global Nanobiotechnology Market |
| Major Market Drivers |
| Where Conventional Molecular Science Falls Short…Nanobio Steps In |
| Nanotechnology Revolutionizes Pharmaceuticals & Healthcare Sector |
| Nanomedicine Market to Achieve Phenomenal Growth |
| Opportunities Galore for Nanomedicine |
| Drug Delivery - A Promising Application Area for Nanotechnology |
| Nanotechnology Offers Huge Potential in Brain Disorder Treatment |
| High Demand for Nanobots and Nano Healthcare Devices |
| Nanotechnology Gaining Prominence for Treatment of Cancer |
| Nanotechnology in Drug Delivery: A Specialized Market Opportunity |
| Commercialization of Nanotechnology-based Medical Products Gains Momentum |
| Nanodiagnostic Products to Witness Strong Demand Growth |
| Dendrimers Serve as a Base to Build Multifunctional Nanodevices |
| Nanotechnology Rescues Poor Water Soluble Drugs from Abandonment |
| Huge Opportunities for Nanomaterials in the Medical Field |
| Commercial Opportunities in Healthcare Sector |
| Future Possibilities |
| Global Market for Fullerenes - An Insight |
| Dawn Breaks on Nanobiotechnology |
| Demystifying the Intriguing World of Nanobiotech |
| A Meeting Place of Medicine’s Best Solutions |
| Nanobiotechnology to Become Viable for All Drug Development Stages |
| Nanoparticles: The Foundation of Nanobiotechnology |
| Improved Optical Properties and Stability of Nanoparticles |
| Nanoemulsions |
| The Promise of Nanobiotechnology |
| Biological Weaponries against Diseases Come in Small Packages |
| Proffered Benefits of Nanobiotechnology |
| Opportunity & Beyond |
| Nanobiotechnology - Will it Live Up to the Expectations? |
| The Future of Nanobiotechnology: Shape of Things to Come |
| Nanobiotechnology: The Outer Limits |
| Futuristics: A Rumination |
| Conclusions |
| Global Competitor Market Shares |
| Nanobiotechnology Competitor Market Share Scenario Worldwide (in %): 2018 & 2029 |
| Impact of Covid-19 and a Looming Global Recession |
| 2. FOCUS ON SELECT PLAYERS |
| Ablynx NV (Belgium) |
| Arrowhead Pharmaceuticals, Inc. (USA) |
| Avadel Pharmaceuticals plc (Ireland) |
| CaPtivate Pharmaceuticals LLC (USA) |
| Celgene Corporation (USA) |
| ELITechGroup (France) |
| GlaxoSmithKline Plc. (UK) |
| Johnson & Johnson (USA) |
| Merck & Co., Inc. (USA) |
| NanoBio® Corporation (USA) |
| Nanophase Technologies Corporation (USA) |
| pSivida Corp. (USA) |
| Sigma-Aldrich Corp. (USA) |
| Starpharma Holdings Ltd. (Australia) |
| Vectura Group plc (UK) |
| 3. MARKET TRENDS & DRIVERS |
| Present Status and Future Opportunities |
| Outlook |
| Developing Countries to Rise over the Horizon |
| Nanomaterials & Nanoparticles Witness Robust Activity |
| Focus on Improved Performance to Bring New Manufacturing Methods for Nanomaterials |
| Why Invest in Nanobiotechnology? |
| Private and Public Companies to Step Up Funding on Nanotechnology |
| United States Lead the Way in Government Funding |
| Increasing Awareness on Technology to Drive Growth |
| Demand for Novel Products to Push Up Growth |
| Nano-Enabled Drug Discovery Holds Tremendous Potential |
| Consolidation Sharpens the Industry's Edge |
| The Regulatory Framework Evolves with the Technology |
| Quantum Dot Patents Pose Legal Tangles |
| Miniaturized Liquid Handling Becomes Progressive |
| Trends in Nanotechnology Enabled Drug Delivery Systems |
| Patent Expiries: A Key Driver |
| Nanotechnology Enabled Drug Delivery to Exhume Unused Drugs |
| 4. GLOBAL MARKET PERSPECTIVE |
| Nanobiotechnology Global Market Estimates and Forecasts in US$ Million by Region/Country: 2018-2025 |
| Nanobiotechnology Global Retrospective Market Scenario in US$ Million by Region/Country: 2009-2017 |
| Nanobiotechnology Market Share Shift across Key Geographies Worldwide: 2009 VS 2019 VS 2025 |
| Pharmaceuticals & Biotechnology Industry (End-Use) Global Opportunity Assessment in US$ Million by Region/Country: 2018-2025 |
| Pharmaceuticals & Biotechnology Industry (End-Use) Historic Sales Analysis in US$ Million by Region/Country: 2009-2017 |
| Pharmaceuticals & Biotechnology Industry (End-Use) Percentage Share Breakdown of Global Sales by Region/Country: 2009 VS 2019 VS 2025 |
| Medical Devices (End-Use) Worldwide Sales in US$ Million by Region/Country: 2018-2025 |
| Medical Devices (End-Use) Historic Demand Patterns in US$ Million by Region/Country: 2009-2017 |
| Medical Devices (End-Use) Market Share Shift across Key Geographies: 2009 VS 2019 VS 2025 |
| III. MARKET ANALYSIS |
| GEOGRAPHIC MARKET ANALYSIS |
| United States |
| Market Facts & Figures |
| US Nanobiotechnology Market Share (in %) by Company: 2018 & 2025 |
| United States Nanobiotechnology Latent Demand Forecasts in US$ Million by End-Use: 2018 to 2025 |
| Nanobiotechnology Historic Demand Patterns in the United States by End-Use in US$ Million for 2009-2017 |
| Nanobiotechnology Market Share Breakdown in the United States by End-Use: 2009 VS 2019 VS 2025 |
| Canada |
| Canadian Nanobiotechnology Market Quantitative Demand Analysis in US$ Million by End-Use: 2018 to 2025 |
| Nanobiotechnology Market in Canada: Summarization of Historic Demand Patterns in US$ Million by End-Use for 2009-2017 |
| Canadian Nanobiotechnology Market Share Analysis by End-Use: 2009 VS 2019 VS 2025 |
| Japan |
| Japanese Demand Estimates and Forecasts for Nanobiotechnology in US$ Million by End-Use: 2018 to 2025 |
| Japanese Nanobiotechnology Market in US$ Million by End-Use: 2009-2017 |
| Nanobiotechnology Market Share Shift in Japan by End-Use: 2009 VS 2019 VS 2025 |
| China |
| Chinese Demand for Nanobiotechnology in US$ Million by End-Use: 2018 to 2025 |
| Nanobiotechnology Market Review in China in US$ Million by End-Use: 2009-2017 |
| Chinese Nanobiotechnology Market Share Breakdown by End-Use: 2009 VS 2019 VS 2025 |
| Europe |
| Market Facts & Figures |
| European Nanobiotechnology Market: Competitor Market Share Scenario (in %) for 2018 & 2025 |
| European Nanobiotechnology Market Demand Scenario in US$ Million by Region/Country: 2018-2025 |
| Nanobiotechnology Market in Europe: A Historic Market Perspective in US$ Million by Region/Country for the Period 2009-2017 |
| European Nanobiotechnology Market Share Shift by Region/Country: 2009 VS 2019 VS 2025 |
| European Nanobiotechnology Addressable Market Opportunity in US$ Million by End-Use: 2018-2025 |
| Nanobiotechnology Market in Europe: Summarization of Historic Demand in US$ Million by End-Use for the Period 2009-2017 |
| European Nanobiotechnology Market Share Analysis by End-Use: 2009 VS 2019 VS 2025 |
| France |
| Nanobiotechnology Quantitative Demand Analysis in France in US$ Million by End-Use: 2018-2025 |
| French Nanobiotechnology Historic Market Review in US$ Million by End-Use: 2009-2017 |
| French Nanobiotechnology Market Share Analysis: A 17-Year Perspective by End-Use for 2009, 2019, and 2025 |
| Germany |
| Nanobiotechnology Market in Germany: Annual Sales Estimates and Forecasts in US$ Million by End-Use for the Period 2018-2025 |
| German Nanobiotechnology Market in Retrospect in US$ Million by End-Use: 2009-2017 |
| Nanobiotechnology Market Share Distribution in Germany by End-Use: 2009 VS 2019 VS 2025 |
| Italy |
| Italian Demand for Nanobiotechnology in US$ Million by End-Use: 2018 to 2025 |
| Nanobiotechnology Market Review in Italy in US$ Million by End-Use: 2009-2017 |
| Italian Nanobiotechnology Market Share Breakdown by End-Use: 2009 VS 2019 VS 2025 |
| United Kingdom |
| United Kingdom Demand Estimates and Forecasts for Nanobiotechnology in US$ Million by End-Use: 2018 to 2025 |
| United Kingdom Nanobiotechnology Market in US$ Million by End-Use: 2009-2017 |
| Nanobiotechnology Market Share Shift in the United Kingdom by End-Use: 2009 VS 2019 VS 2025 |
| Rest of Europe |
| Rest of Europe Nanobiotechnology Addressable Market Opportunity in US$ Million by End-Use: 2018-2025 |
| Nanobiotechnology Market in Rest of Europe: Summarization of Historic Demand in US$ Million by End-Use for the Period 2009-2017 |
| Rest of Europe Nanobiotechnology Market Share Analysis by End-Use: 2009 VS 2019 VS 2025 |
| Asia-Pacific |
| Nanobiotechnology Quantitative Demand Analysis in Asia-Pacific in US$ Million by End-Use: 2018-2025 |
| Asia-Pacific Nanobiotechnology Historic Market Review in US$ Million by End-Use: 2009-2017 |
| Asia-Pacific Nanobiotechnology Market Share Analysis: A 17-Year Perspective by End-Use for 2009, 2019, and 2025 |
| Rest of World |
| Rest of World Nanobiotechnology Market Quantitative Demand Analysis in US$ Million by End-Use: 2018 to 2025 |
| Nanobiotechnology Market in Rest of World: Summarization of Historic Demand Patterns in US$ Million by End-Use for 2009-2017 |
| Rest of World Nanobiotechnology Market Share Analysis by End-Use: 2009 VS 2019 VS 2025 |
| IV. COMPETITION |
| Total Companies Profiled : 80 Click here to request a full table of contents and more details on this project. |
INSIDER ACCESS TO
Registration is required to access our data stacks.
RESEARCH PANEL
Panelists are carefully chosen based on their domain expertise and market influence.
Participation in our expert panels is only by invitation. Our project focused panels are constituted of senior executives in business strategy, marketing, sales, and product management at competitive companies worldwide. We also welcome individuals from leading management consulting, venture capital, private equity, investment management and related firms with domain expertise and are actively monitoring specific companies or industries. Our panelists bring unique market perspectives and unbiased intelligence to our ongoing research programs.
Our panelists give 30-minutes a month or a one-time 30-minute participation based on their time and willingness.
- Complimentary previews of full stack research data for participated
- Insider access to research programs including engagements and stats from other panelists
- Unlimited research credits of $1000 per participated project
- Competitive Intelligence Alerts including engagements from other panelists and validated participants worldwide relevant to your company
- Interact with other panelists via our MarketGlassTM Data Exchange Platform*
- BlogX - Panelists can use our blogging platform publish their viewpoints on news relevant to their domain expertise. Platform enables panelists to share their viewpoints on current news and events related to their areas domain expertise with timely and insightful blogs*
* Complete details will be shared with panelists upon formal acceptance.
Our robust permission-based engagement strategy requires a one-time double opt-in and/or re-consent for all users. We will re-establish consent once a year from date of last use. Both these practices exceed GDPR mandates.
What we store: Primary coordinates such as email, company address and phone. In-house developed influencer rank.
How we store: Encrypted and additionally secured by firewalls.
How we use your data: Only to contact you directly. We never share your coordinates with any individual or entity outside our company for any reason.
Privacy queries: Privacy@StrategyR.com